Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment Outcomes.
Journal: Focus (American Psychiatric Publishing)
Published: August 11, 2026
Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study.
Journal: Focus (American Psychiatric Publishing)
Published: August 01, 2026
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial.
Journal: The Journal of clinical psychiatry
Published: May 07, 2026
Concurrent SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine Treatment.
Journal: The Journal of clinical psychiatry
Published: May 07, 2026
Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.
Journal: CNS drugs
Published: February 25, 2026
Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.
Journal: Fundamental & clinical pharmacology
Published: February 04, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol.
Journal: Contemporary clinical trials
Published: October 02, 2025
Ketamine and Esketamine: Is There a Meaningful Clinical Difference?
Journal: The Journal of clinical psychiatry
Published: September 26, 2025
Real-World Outcomes of Brexanolone to Treat Postpartum Depression.
Journal: Women's health reports (New Rochelle, N.Y.)
Published: September 12, 2025
Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human Studies.
Journal: The American journal of psychiatry
Published: September 10, 2025
Impact of cannabis use on health outcomes and prescription benzodiazepine use.
Journal: medRxiv : the preprint server for health sciences
Published: September 05, 2025
Comparing the Cognitive Effects of Repeated Intravenous Ketamine and Electroconvulsive Therapy in Patients With Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial.
Journal: The Journal of clinical psychiatry
Published: September 03, 2025
Last Updated: 09/26/2026